— Know what they know.
Not Investment Advice

RLYB NASDAQ

Rallybio Corporation
1W: +2.8% 1M: +0.8% 3M: +8.7% YTD: +201.8% 1Y: +3191.6% 3Y: +385.2% 5Y: +22.9%
$17.08
+0.32 (+1.91%)
 
Weekly Expected Move ±3.9%
$16 $16 $17 $18 $18
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 56 · $90.6M mcap · 3M float · 2.41% daily turnover · Short 23% of daily vol

Balance Sheet Trends

Total Assets
$62M -8.6% ▼
5Y CAGR: -15.2%
Total Liabilities
$4M -33.3% ▼
5Y CAGR: -6.0%
Shareholders Equity
$58M -6.0% ▼
5Y CAGR: -15.7%
Cash & Investments
$55M -16.4% ▼
5Y CAGR: -17.2%
Total Debt
$176K +14.3% ▲
Net Debt
-$31M -126.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$175M$57M$24M$14M$31M
Short-Term Investments$0$112M$85M$52M$23M
Cash & ST Investments$175M$169M$110M$66M$55M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$395K$1M$2M$995K$7M
Total Current Assets$181M$179M$115M$68M$61M
Property, Plant & Equip.$511K$909K$592K$267K$198K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$805K$30K$239K$0$0
Other Non-Current Assets$0$0$0$0$810K
Total Non-Current Assets$1M$939K$831K$267K$1M
Total Assets$182M$180M$116M$68M$62M
— Liabilities —
Accounts Payable$603K$1M$976K$278K$126K
Short-Term Debt$0$0$0$0$94K
Deferred Revenue$0$0$0$848K$212K
Other Current Liabilities$3M$5M$3M$3M$4M
Total Current Liabilities$7M$11M$9M$6M$4M
Long-Term Debt$0$0$0$0$82K
Other Non-Current Liab.$32K$0$0$0$0
Total Non-Current Liabilities$32K$374K$173K$212K$82K
Total Liabilities$7M$11M$9M$6M$4M
— Equity —
Common Stock$3K$4K$4K$4K$4K
Retained Earnings-$94M-$161M-$235M-$293M-$302M
Accumulated OCI$0-$214K$15K$68K$18K
Total Stockholders Equity$176M$169M$106M$62M$58M
Total Liabilities & Equity$182M$180M$116M$68M$62M
— Key Metrics —
Total Debt$0$555K$392K$154K$176K
Net Debt-$175M-$56M-$24M-$14M-$31M
Total Investments$805K$112M$86M$52M$23M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms